NCT00060528View on ClinicalTrials.gov

Sequential Vaccinations in Prostate Cancer Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 22, 2003

Primary Completion Date

March 7, 2006

Study Completion Date

June 8, 2009

Conditions
Prostatic Neoplasms
Interventions
DRUG

Recombinant Fowlpox-GM-CSF

DRUG

Recombinant Fowlpox-PSA (L155)-TRICOM (PROSTVAC-F/TRICOM)

DRUG

Recombinant Vaccinia-PSA (L155)-TRICOM (PROSTVAC-V/TRICOM)

DRUG

Recombinant Human GM-CSF

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00060528 - Sequential Vaccinations in Prostate Cancer Patients | Biotech Hunter | Biotech Hunter